Andrew Stone
Andrew Stone
Latest posts from :
Although the list of cell and gene therapies is growing, prices remain high....
Attempts to make trials more diverse aren’t working. To overcome far-reaching...
The pandemic is serving as an accelerated lesson in the possibilities of...
Pharma’s gradual evolution into digital-first commercial has become urgent in...
A new pandemic-driven technological revolution is reshaping the entire...
Breakthrough CGT therapies are coming thick and fast, now pharma must work on...
The Astellas head of medical affairs follows up with answers to questions...
Key opinion leaders who evolve into the digital sphere to become digital...
In the face of massive patient need, there’s plenty pharma can do to help....
Takeda is building on strong stakeholder relationships it has nurtured...